Pharmaceuticals, Biotechnology and Life Sciences
REBLOZYL is the first and only FDA-approved erythroid maturation agent, representing a new class of therapy for these patients Approval…
—New Data at ACAAI Reinforce the Need for Treatments to Reduce the Fear of Accidental Exposure to Peanut and Improve…
— Findings Suggest that a Strong Clinical History, in Combination with Evidence of Peanut Sensitization, is the Optimal Approach to…
DUBLIN–(BUSINESS WIRE)–The “Neurontin- Drug Insight, 2019” report has been added to ResearchAndMarkets.com’s offering. “Neurontin Drug Insight, 2019” highlights the drug…
Biodesix Named Company of the Year, Securisyn Medical Honored as Rising Star DENVER–(BUSINESS WIRE)–#cobioscience—Colorado BioScience Association celebrated the companies and…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it has commenced tender offers (the “Offers”) to…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Limited (NYSE and TASE: TEVA) (“Teva”) announced today the following private offering of senior notes: Teva…
Expanded Pipeline and Clinical Data Milestones Propel Company to Top Spot BOULDER, Colo.–(BUSINESS WIRE)–Biodesix, Inc. has been named Company of…
DUBLIN–(BUSINESS WIRE)–The “US Overactive Bladder (Anticholinergics & Beta Adrenoreceptor Agonists) Market Report: Insights, Trends and Forecast (2021-2031)” report has been…
Small-volume presentation now available exclusively in FDA-approved ready-to-administer prefilled syringe LAKE ZURICH, Ill.–(BUSINESS WIRE)–Fresenius Kabi announced today the availability in…